99.4% HPLC
LOT NL2S0S003 · 2–8°C · REL 05 / 2025
29 residues · Lyophilised powder
CJC-1295
5 MG
99.1% RP-HPLC
In stock · 19 vials
| CAS number | 863288-34-0 |
|---|---|
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.90 g/mol |
| Sequence | Y-(D-Ala)-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂ |
| Appearance | White lyophilised powder |
| Solubility | Water; 0.1% acetic acid |
| Released lot | NL2S0S003 |
| Manufactured / expiry | 05 / 2025 / 05 / 2027 |
| Storage | 2–8°C · do not freeze · protect from light |
$82.00
$82.00 per vial
1
| 1+ | 3+ | 5+ | 10+ |
|---|---|---|---|
| $82.00 | $77.08 | $72.16 | $65.60 |
- Lot-keyed certificate of analysis — open COA for NL2S0S003
- Cold chain at 2–8°C with temperature indicator
- Complimentary shipping over $200.00 · dispatched within the United States
Primary sequence
29 residues.
GHRH(1-29) analogue · D-Ala², Gln⁸, Ala¹⁵, Leu²⁷, C-terminal amide
| One-letter | Y-(D-Ala)-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂ |
|---|---|
| Residue count | 29 |
| PubChem CID | 56841945 |
Analytical release · lot NL2S0S003
Full certificate →
The trace, not the adjective.
Separated by reversed-phase HPLC and read at 220 nm; identity confirmed by ESI‑MS against theoretical mass.
| Purity (RP-HPLC) | 99.1% |
|---|---|
| Identity (ESI-MS) | 3368.4 [M+H]⁺ |
| Water (Karl Fischer) | 4.4% |
| Acetate content | 8.2% |
| Net peptide content | 80.7% |
| Endotoxin | < 5 EU/mg |
RP-HPLC · LOT NL2S0S003
CJC-1295
COLUMN C18, 4.6 × 250 MM
FLOW 1.0 ML/MIN
DETECT UV 220 NM
Other compounds
All materials are supplied for in vitro laboratory research by qualified professionals. Not for human consumption. Not for veterinary, diagnostic or therapeutic use.